Neural antibodies can specifically label and recognize molecules on nerve cells, enabling a more comprehensive understanding and study of the biological properties, functions, and mechanisms of nerve cells in neurodegenerative diseases.
Covering iPSC neural cells, brain organoids, and microelectrode array services, our tools support neural development, disease modeling, and drug screening with high quality and reliable performance to meet diverse research needs.
Number of Launched Drugs:0 Number of Drugs in Clinical Trials:0 Lastest Research Phase:Discontinued
Product Inquiry
* We couldn't find what you're looking for. You can let us help by filling the form below. Our
tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information
will be kept strictly confidential.
Synonym Name
Fz-10, FZD10, hFz10, FzE7, CD350
Background
Frizzled-10 (FZD10) is also known as FzE7 or CD350, which belongs to the G-protein coupled receptor Fz/Smo family. Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. FZD10 contains one FZ (frizzled) domain. FZD10 protein is a cell surface receptor, which is activated by Wnt proteins and involved in the regulation of cellular function. FZD10 interacts with WNT7B and MYOC.